Skip to Content


MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

International Parkinson and Movement Disorder Society


Neuroimaging Study Group

Main Content

Join now »

Have questions? Contact the group's MDS Staff Liaison, Abigail Kopchinski, at

Our study group brings together clinical experts and researchers who apply neuroimaging technologies in parkinsonian and other movement disorders. Our aim is to foster translation of research from basic to clinical science and to accelerate the deployment of more advanced clinical standards of neuroimaging in these disorders. To this end, we develop collaborations and studies centered on clinical, preclinical, and translational approaches. 

About the Neuroimaging Study Group  

Advances in neuroimaging techniques improved our ability to evaluate basal ganglia functions, to understand pathophysiological and therapeutic mechanisms in Parkinson’s disease, atypical parkinsonian disorders and other movement disorders, to diagnose parkinsonian syndromes and monitor disease progression.  Imaging methods like positron emission tomography (PET), single-photon emission computed tomography (SPECT), magnetic resonance imaging (MRI), electro- /magnetoencephalography (EEG/MEG), have been used both in patient groups and animal models to investigate neuropathological mechanisms and/or compensatory changes underlying motor and non-motor symptoms, treatment-related complications (e.g., impulse control disorders), and as a biomarker for diagnosis, prognosis and disease monitoring.

Mission and Objectives  
  • To improve our understanding of pathophysiological and therapeutic mechanisms in movement disorders including cellular metabolism, neuroinflammation, protein deposition, receptor abnormalities, (micro-)structural disintegration, and consequences for anatomical and functional brain connectivity
  • To facilitate and promote cross-collaboration among preclinical and clinical researchers
  • To create critical synergies for “big-imaging-data”-research, i.e., the collection, curation, and analysis of multicentric neuroimaging data
  • To deploy latest advances in data and imaging science for the development of imaging biomarkers supporting personalized diagnostics and treatments

MDS Neuroimaging Study Group members gather at the 20th International Congress in Berlin in June 2016.


Thilo van Eimeren

Vice Chair
Cecilia Peralta

Steering Committee
Jee Young Lee, South Korea
Oury Monchi, Canada
Cecilia Peralta, Argentina
Irena Rektorova, Czech Republic
Kristina Simonyan, USA
Antonio P Strafella, Canada
Alessandro Tessitore, Italy
Thilo van Eimeren, Germany

Resource Type

Please wait while we gather your results.

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including and This cookie policy only covers the primary and domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice